171 related articles for article (PubMed ID: 11470758)
21. Oncogenic human papillomaviruses block expression of the B-cell translocation gene-2 tumor suppressor gene.
Cullmann C; Hoppe-Seyler K; Dymalla S; Lohrey C; Scheffner M; Dürst M; Hoppe-Seyler F
Int J Cancer; 2009 Nov; 125(9):2014-20. PubMed ID: 19551855
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
24. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.
Kawakubo H; Carey JL; Brachtel E; Gupta V; Green JE; Walden PD; Maheswaran S
Oncogene; 2004 Oct; 23(50):8310-9. PubMed ID: 15378000
[TBL] [Abstract][Full Text] [Related]
25. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling.
Park S; Lee YJ; Lee HJ; Seki T; Hong KH; Park J; Beppu H; Lim IK; Yoon JW; Li E; Kim SJ; Oh SP
Mol Cell Biol; 2004 Dec; 24(23):10256-62. PubMed ID: 15542835
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
Imran M; Lim IK
Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
[TBL] [Abstract][Full Text] [Related]
27. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.
Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI
Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
Sasajima H; Nakagawa K; Yokosawa H
Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
[TBL] [Abstract][Full Text] [Related]
29. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
30. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
31. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement.
Hata K; Nishijima K; Mizuguchi J
Exp Cell Res; 2007 Jul; 313(11):2356-66. PubMed ID: 17466295
[TBL] [Abstract][Full Text] [Related]
32. Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line.
Lecane PS; Kiviharju TM; Sellers RG; Peehl DM
Prostate; 2003 Mar; 54(4):258-67. PubMed ID: 12539224
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of beta-catenin by activated p53.
Sadot E; Geiger B; Oren M; Ben-Ze'ev A
Mol Cell Biol; 2001 Oct; 21(20):6768-81. PubMed ID: 11564862
[TBL] [Abstract][Full Text] [Related]
34. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
[TBL] [Abstract][Full Text] [Related]
35. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki CG; Huibregtse JM; Howley PM
Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
[TBL] [Abstract][Full Text] [Related]
36. BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.
Huang CS; Zhai JM; Zhu XX; Cai JP; Chen W; Li JH; Yin XY
Dig Dis Sci; 2017 Dec; 62(12):3501-3510. PubMed ID: 29098552
[TBL] [Abstract][Full Text] [Related]
37. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN
Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
[TBL] [Abstract][Full Text] [Related]
38. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
39. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
40. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex.
Rouault JP; Prévôt D; Berthet C; Birot AM; Billaud M; Magaud JP; Corbo L
J Biol Chem; 1998 Aug; 273(35):22563-9. PubMed ID: 9712883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
